BioCentury
ARTICLE | Distillery Therapeutics

Gastrointestinal; autoimmune disease

July 25, 2018 3:30 PM UTC

Mouse studies suggest inhibiting LRRK2 could help treat colitis and Crohn disease. In dendritic cells from eight Crohn patients, four LRRK2 inhibitor tool compounds decreased levels of inflammatory cy...